Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Hemorrhagic episodes"'
Autor:
Dongqing Liu, Fei Yuan, Heguan Fu, Yao He, Hongtao Zhang, Cong Han, Lichen Zhang, Mingming Lu, Fugeng Sheng, Shitong Liu, Peng Peng, Xihai Zhao, Jianming Cai, Qian Zhang, Yuan Liu, Xu Liu
Publikováno v:
Journal of Neurology. 268:4768-4777
This study aimed to investigate the enhancement characteristics of vessel wall in patients with moyamoya disease (MMD) using 3D high-resolution magnetic resonance (MR) imaging and their relationship with initial and recurrent intracranial hemorrhage.
Publikováno v:
Radiology Case Reports, Vol 16, Iss 7, Pp 1777-1779 (2021)
Radiology Case Reports
Radiology Case Reports
The coronavirus disease 2019 (COVID-19) is characterized by viral pneumonia with mild to moderate symptoms. Emerging studies suggest that some patients may experience uncommon complications, such as thrombotic or hemorrhagic episodes. Here we present
Publikováno v:
Archivos de Medicina (Manizales). 18:172-180
La hemofilia es una patología derivada de la deficiencia heredada de factores de la coagulación, comúnmente ligada al cromosoma X que presenta diferentes tipos de hemorragias. Clínicamente la hemofilia se clasifica según la deficiencia del facto
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Russian Journal of Children Hematology and Oncology. 4:61-70
Effectiveness and safety of domestic recombinant factor VIII (FVIII) with removed B-domain (moroctocogum alfa, Octofactor®, JC “Generium”) usage for preventive treatment of 12 adolescents at age 12–17 years old with severe hemophilia A describ
Publikováno v:
Russian Journal of Children Hematology and Oncology. 4:20-32
The multicentre prospective open uncontrolled study investigated efficiency and safety of national recombinant factor IX (rFIX, nonacog alfa, Innonafactor®, JSC “Generium” for preventive treatment of 15 patients at the age of 12 years and older
Publikováno v:
Neuro-Oncology
BACKGROUND MEK and BRAF inhibitors are increasingly common treatments for pediatric nervous system tumors. While effective in blocking Ras/Raf/MEK/ERK pathway activation driving tumor progression, the side effect profile differs from traditional cyto
BACKGROUND: Optimal management of recurrent high grade gliomas continues to be challenging, with Bevacizumab as one of the modalities increasingly used in the last few years. The current audit looks at the pattern of use and its results from a major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce6072bf708f229b90d3ef24484ce230
https://europepmc.org/articles/PMC5463884/
https://europepmc.org/articles/PMC5463884/
Publikováno v:
Journal of Neurotrauma. 31:670-673
Chronic subdural hematoma (CSH) is characterized by a net increase of volume over time. Major underlying mechanisms appear to be hemorrhagic episodes and a continuous exudation, which may be studied using labeled proteins to yield an exudation rate i
Publikováno v:
Blood Coagulation & Fibrinolysis. 29:415-416
A 65-year-old woman originating from the French Basque country presented with a past medical history of three unexplored hemorrhagic episodes. They included prolonged bleeding after adenoidectomy and tooth extractions and a postpartum hemorrhage requ